Description
Galiximab (IDEC 114) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody directed against the CD80 antigen and blocks CD80–CD28 binding. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma.
Cat.No
A763
Name
Galiximab
Chemical Properties
CAS
357613-77-5
Synonyms
galiximab;Anti-cd80 monoclonal antibody;Galiximab [inn];Idec 114;Idec-114;Immunoglobulin G1, anti-(human cd80 (antigen)) (human-macaca irus monoclonal idec-114 heavy chain), disulfide with human-macaca irus monoclonal idec-114 lamda chain, dimer;Unii-S9ox9692zb;Research Grade Galiximab(DHE03401)
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
